Lacrimal Duct Obstruction

Subscribe to Selected New Research on Lacrimal Duct Obstruction

14 relevant articles (0 outcomes, 2 trials/studies) found for this Disease

Description: Interference with the secretion of tears by the lacrimal glands. Obstruction of the lacrimal sac or nasolacrimal duct causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Also Known As:

Duct Obstruction, Lacrimal; Duct Obstructions, Lacrimal; Lacrimal Duct Obstructions; Obstruction, Lacrimal Duct; Obstructions, Lacrimal Duct

Disease Context: Research Results

Eye Diseases: 1245

Lacrimal Apparatus Diseases: 274

Lacrimal Duct Obstruction: 14

Related Diseases

1.	Strabismus (Squint)
2.	Microcephaly
3.	Mental Retardation (Idiocy)
4.	Lacrimal Apparatus Diseases (Epiphora)
5.	Atrial Heart Septal Defects (Atrial Septal Defect)

Experts

1.	Soler Machín, J: 1 article (06/2003)
2.	Cristóbal Bescós, J A: 1 article (06/2003)
3.	Castillo Laguarta, J M: 1 article (06/2003)
4.	De Gregorio Ariza, M A: 1 article (06/2003)
5.	Medrano, J: 1 article (06/2003)
6.	Cervenka, S: 1 article (01/2003)
7.	Komínek, P: 1 article (01/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lacrimal Duct Obstruction:

1.	SiliconesIBA 09/01/2005 - "In our study, dacryoscintigraphy results of patients with functional lacrimal duct obstruction are newly classified into three types, the effects and prognoses of silicone tube intubation are noted according to each type, and the role of dacryoscintigraphy in determining appropriate surgical approaches is evaluated" 09/01/2005 - "Impression of functional lacrimal duct obstruction was made through dacryoscintigraphy, and silicone tubes were inserted" 05/01/1997 - "Silicone intubation--treatment of complicated conditions of congenital lacrimal duct obstruction]" 06/01/1988 - "Silicone intubation for the treatment of congenital lacrimal duct obstruction: successful results removing the tubes after six weeks." 01/01/2003 - "Significance of the fluorescein dye disappearance test (FDDT) in the removal of the silicone cannula and prognosis in congenital lacrimal duct obstruction]" Order ALL the reference details at left...
2.	Fluorescein (Funduscein)FDA Link 01/01/2003 - "Significance of the fluorescein dye disappearance test (FDDT) in the removal of the silicone cannula and prognosis in congenital lacrimal duct obstruction]" Order ALL the reference details at left...
3.	SiliconIBA 01/01/1985 - "Therefore a conservatively unsuccessfully treated lacrimal duct obstruction in infants should be followed by high pressure irrigation and if necessary by silicon intubation of the lacrimal system." Order ALL the reference details at left...
4.	Polyurethanes (Polyurethane)IBA 06/01/2003 - "OBJECTIVE: To analyze a series of patients with lacrimal duct obstruction treated with polyurethane stents" Order ALL the reference details at left...
5.	Adrenal Cortex Hormones (Corticosteroids)IBA 01/01/1962 - "CORTICOSTEROIDS AND FIBROLYSIN IN THE PREVENTION OF LACRIMAL DUCT OBSTRUCTION." Order ALL the reference details at left...
6.	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 06/01/2003 - "MATERIAL AND METHODS: We studied 125 cases of lacrimal duct obstruction corresponding to 115 patients, of whom 30 were males (26.08%) and 85 females (73.91%)" Order ALL the reference details at left...
7.	alovudineIBA 01/01/2003 - "Significance of the fluorescein dye disappearance test (FDDT) in the removal of the silicone cannula and prognosis in congenital lacrimal duct obstruction]" Order ALL the reference details at left...

Therapies and Procedures

1.	Dacryocystorhinostomy 10/01/1999 - "CONCLUSION: Naso-lacrimal duct dilatation and stenting is a viable alternative to conventional dacryocystorhinostomy in the treatment of naso-lacrimal duct obstruction and merits a larger trial." 09/01/2007 - "Eleven cases of recurrent lacrimal duct obstruction after external dacryocystorhinostomy were submitted to endoscopic dacryocystorhinostomy" 09/01/2007 - "OBJECTIVES: To observe the benefit of endoscopic surgery for the treatment of lacrimal duct obstruction in revisional surgeries after external dacryocystorhinostomy" 01/01/1996 - "Dacryocystorhinostomy together with temporary intubation of lacrimal canaliculi as a method of treatment of lacrimal duct obstruction]" 09/01/1988 - "Treatment of lacrimal duct obstruction using dacryocystorhinostomy]" Order ALL the reference details at left...
2.	Stents 06/01/2003 - "Lacrimal duct obstruction treated with lacrimonasal stent]" 10/01/1999 - "This pilot project aimed to evaluate the use of stents as an alternative approach to the treatment of naso-lacrimal duct obstruction" 06/01/2003 - "OBJECTIVE: To analyze a series of patients with lacrimal duct obstruction treated with polyurethane stents" Order ALL the reference details at left...
3.	Autologous Transplantation (Autograft) 04/01/1975 - "Technical variant of autograft for lacrimal duct obstruction]" Order ALL the reference details at left...
4.	Sutures (Suture) 01/01/1984 - "The propositus was a 16-month-old caucasian male with 1) mental retardation, 2) congenital microcephaly, 3) postnatal growth deficiency, 4) ridged metopic suture with narrow bifrontal diameter, 5) upslanted palpebral fissures with persistent epicanthal folds, strabismus, and lacrimal duct obstruction, 6) narrow palate, 7) macrodontia, 8) anteverted ears, 9) atrial septal defect, 10) dry brittle scalp hair and 11) cutis marmorata" Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Lacrimal Duct Obstruction

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 0 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>